Options to restrict hematoma expansion after spontaneous intracerebral hemorrhage.
about
Principles and Clinical Application of Dual-energy Computed Tomography in the Evaluation of Cerebrovascular DiseaseNeuroprotective effect of therapeutic hypothermia versus standard care alone after convulsive status epilepticus: protocol of the multicentre randomised controlled trial HYBERNATUSSteps to consider in the approach and management of critically ill patient with spontaneous intracerebral hemorrhageModeling intracerebral hemorrhage growth and response to anticoagulationCharacterization of the brain injury, neurobehavioral profiles, and histopathology in a rat model of cerebellar hemorrhage.Warfarin-related intraventricular hemorrhage: imaging and outcome.Surgery versus Conservative Treatment for Spontaneous Supratentorial Intracerebral Hemorrhage in Spot Sign Positive Patients.Early prediction of death in acute hypertensive intracerebral hemorrhage.Evaluation of the hematoma consequences, neurobehavioral profiles, and histopathology in a rat model of pontine hemorrhage.European research priorities for intracerebral haemorrhage.The practical management of intracerebral hemorrhage associated with oral anticoagulant therapy.Pharmacological prophylaxis of venous thromboembolism during acute phase of spontaneous intracerebral hemorrhage: what do we know about risks and benefits?Minimally invasive endoscopic surgery for treatment of spontaneous intracerebral haematomas.Blood pressure reduction and noncontrast CT markers of intracerebral hemorrhage expansion.Intensive Blood Pressure Reduction and Spot Sign in Intracerebral Hemorrhage: A Secondary Analysis of a Randomized Clinical Trial.Noncontrast Computed Tomography Markers of Intracerebral Hemorrhage Expansion.Does prior antiplatelet therapy influence hematoma volume and hematoma growth following intracerebral hemorrhage? Results from a prospective study and a meta-analysis.Leukocyte Count and Intracerebral Hemorrhage Expansion.Relationship between cellular apoptosis and the expression of p75 neurotrophin receptor and tyrosine kinase A receptor in tissue surrounding haematoma in intracerebral haemorrhage.Intracerebral hemorrhage during anticoagulation with vitamin K antagonists: a consecutive observational study.Effects of celecoxib on hematoma and edema volumes in primary intracerebral hemorrhage: a multicenter randomized controlled trial.Predictors of hematoma expansion predictors after intracerebral hemorrhage.CM352 Reduces Brain Damage and Improves Functional Recovery in a Rat Model of Intracerebral Hemorrhage.Intravenous tranexamic acid for hyperacute primary intracerebral hemorrhage: Protocol for a randomized, placebo-controlled trial.Role of prothrombin complex concentrate (PCC) in Acute Intracerebral Hemorrhage with Positive CTA spot sign: An institutional experience at a regional and state designated stroke center.Temporal changes in perihematomal apparent diffusion coefficient values during the transition from acute to subacute phases in patients with spontaneous intracerebral hemorrhage.Statistical analysis plan for the 'Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage' (TICH-2) trial.The association between hyperglycemia and the prognosis of acute spontaneous intracerebral hemorrhage.Comparison of Swirl Sign and Black Hole Sign in Predicting Early Hematoma Growth in Patients with Spontaneous Intracerebral Hemorrhage.International normalised ratio normalisation in patients with coumarin-related intracranial haemorrhages--the INCH trial: a randomised controlled multicentre trial to compare safety and preliminary efficacy of fresh frozen plasma and prothrombin comTranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial.Treatment of intracerebral haemorrhage with tranexamic acid – A review of current evidence and ongoing trials
P2860
Q26741897-089B3C05-338C-4FF1-9918-044D8934ACA7Q26744214-217A1001-5CA6-4117-B628-573BA250F161Q26799392-A13C0C75-BBF1-4C93-A8AC-CCBD99F58318Q27342135-55B1FA61-F812-4B27-928D-F2A2E4635A43Q34482285-9A981624-62B7-46E1-958A-2A3F9284BB5AQ35599518-900909AE-0095-4B43-871C-525E7E9DB5B9Q36297341-43486BCA-3E87-4352-A146-6EBD28189B1DQ36502174-E2490D56-E555-4D51-AA43-CE2B16EF46F9Q36600521-980874E8-884D-442A-93B2-71A3EB3828A1Q37017398-6F6BC3EA-ECA9-4196-BB73-0E6D923E2C08Q37873969-F963C8B1-0CCD-4F92-9BD3-56BED9C5B281Q38011567-4D650B14-2D9A-4543-B736-BE355D3251C3Q38357616-6AB170D8-B2B5-4655-A034-9F911E00D04BQ38374087-B579CD85-9ACB-456A-96D1-85193233DA99Q38375358-8EA492F9-0D19-4FAC-B423-F80468EF0C9DQ39176601-62DAA78E-4D5F-4B85-8A1C-56342FA8610EQ39228058-CEF35243-7917-462D-B813-A067A478BC26Q41851667-6F9C32C3-3064-4557-A77E-4E0C0540B170Q42489933-B7CD0D68-6045-4E4D-948E-FE1E98E65C90Q43574054-81442E06-FD90-4C92-906F-3763F115AF06Q45854165-9F766E29-4620-4033-8825-933161489F21Q46191310-5332829D-22FE-4059-AF7C-4C3B6B0AC0DEQ47165301-DC824690-2D9A-424C-A1C0-5F380E69FE26Q47443820-95C2779F-6561-4AC8-94E1-E75FD6F73EE6Q47861634-1D7CE4A6-2B8D-4AC8-8DC0-1AD571AD5337Q48372934-8AF6D830-B3C8-40C4-97C8-55C6FB70EC9CQ48374871-AF50DDFE-66B6-4AAA-BB8D-BF324AD289A0Q48381619-A44DAFEC-31AC-4136-8F27-C1D554994268Q49634284-D95DB543-8864-4200-96D1-0C9F820CECC9Q53226046-E83D5D7D-44A9-453D-BB77-ABA6C8B7F20FQ55395487-021B3C15-A49F-43F7-B0BB-72D7ABAC347FQ58438976-A3A1B316-7757-429D-8EE0-BD42AB0AFAA9
P2860
Options to restrict hematoma expansion after spontaneous intracerebral hemorrhage.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Options to restrict hematoma expansion after spontaneous intracerebral hemorrhage.
@en
Options to restrict hematoma expansion after spontaneous intracerebral hemorrhage.
@nl
type
label
Options to restrict hematoma expansion after spontaneous intracerebral hemorrhage.
@en
Options to restrict hematoma expansion after spontaneous intracerebral hemorrhage.
@nl
prefLabel
Options to restrict hematoma expansion after spontaneous intracerebral hemorrhage.
@en
Options to restrict hematoma expansion after spontaneous intracerebral hemorrhage.
@nl
P1433
P1476
Options to restrict hematoma expansion after spontaneous intracerebral hemorrhage.
@en
P2093
Julian Bösel
Thorsten Steiner
P304
P356
10.1161/STROKEAHA.109.552919
P407
P577
2009-12-31T00:00:00Z